<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="Activity\PMC7765196\results\search\disease\results.xml">
  <result pre="and identification of bioactive compounds from MO leaf against MDA-MB-231" exact="breast cancer" post="cells. MO leaf was sequentially extracted with hexane, ethyl"/>
  <result pre="identification of bioactive compounds from MO leaf against MDA-MB-231 breast" exact="cancer" post="cells. MO leaf was sequentially extracted with hexane, ethyl"/>
  <result pre="in the field of anticancer substances. Moringa oleifera triple negative" exact="breast cancer" post="MDA-MB-231 oleamide 7-octenoic acid 1-phenyl-2-pentanol LC-ESI-QTOF-MS/MS 1. Introduction Breast"/>
  <result pre="the field of anticancer substances. Moringa oleifera triple negative breast" exact="cancer" post="MDA-MB-231 oleamide 7-octenoic acid 1-phenyl-2-pentanol LC-ESI-QTOF-MS/MS 1. Introduction Breast"/>
  <result pre="cancer MDA-MB-231 oleamide 7-octenoic acid 1-phenyl-2-pentanol LC-ESI-QTOF-MS/MS 1. Introduction Breast" exact="cancer" post="is the most frequently diagnosed cancer in women and"/>
  <result pre="LC-ESI-QTOF-MS/MS 1. Introduction Breast cancer is the most frequently diagnosed" exact="cancer" post="in women and is one of the leading causes"/>
  <result pre="in women and is one of the leading causes of" exact="cancer" post="death for women. Worldwide, over 1.3 million cases of"/>
  <result pre="death for women. Worldwide, over 1.3 million cases of invasive" exact="breast cancer" post="are diagnosed and more than 450,000 women die from"/>
  <result pre="for women. Worldwide, over 1.3 million cases of invasive breast" exact="cancer" post="are diagnosed and more than 450,000 women die from"/>
  <result pre="cancer are diagnosed and more than 450,000 women die from" exact="breast cancer" post="annually [1,2]. Breast cancer is a heterogeneous disease with"/>
  <result pre="are diagnosed and more than 450,000 women die from breast" exact="cancer" post="annually [1,2]. Breast cancer is a heterogeneous disease with"/>
  <result pre="than 450,000 women die from breast cancer annually [1,2]. Breast" exact="cancer" post="is a heterogeneous disease with distinct pathological entities and"/>
  <result pre="therapeutic interventions. Approximately 10â€&quot;20% of invasive breast cancers are triple-negative" exact="breast cancer" post="(TNBC) which is defined as the absence of estrogen"/>
  <result pre="interventions. Approximately 10â€&quot;20% of invasive breast cancers are triple-negative breast" exact="cancer" post="(TNBC) which is defined as the absence of estrogen"/>
  <result pre="extracts have been shown to disrupt the proliferation of different" exact="cancer" post="cell lines, for example the hot aqueous MOL extract"/>
  <result pre="example the hot aqueous MOL extract induced apoptosis in human" exact="lung cancer" post="A549 cells by affecting mitochondrial viability in a ROS-dependent"/>
  <result pre="the hot aqueous MOL extract induced apoptosis in human lung" exact="cancer" post="A549 cells by affecting mitochondrial viability in a ROS-dependent"/>
  <result pre="proteins [30]. The methanolic MOL extract induced apoptosis in human" exact="cervical cancer" post="HeLa cells by promoting DNA fragmentation [31]. Moreover, oral"/>
  <result pre="[30]. The methanolic MOL extract induced apoptosis in human cervical" exact="cancer" post="HeLa cells by promoting DNA fragmentation [31]. Moreover, oral"/>
  <result pre="administration of cold aqueous MOL extract induced apoptosis of human" exact="hepatocellular carcinoma" post="HepG2 cells by affecting the apoptosis-related proteins Bcl-2 and"/>
  <result pre="by affecting the apoptosis-related proteins Bcl-2 and caspase-3 [32]. In" exact="breast cancer," post="most of the previous studies of MOL extracts have"/>
  <result pre="extracts have used the MCF-7 cell line, a hormone receptor-positive" exact="breast cancer" post="model [32,33]. Only one study has investigated the effect"/>
  <result pre="have used the MCF-7 cell line, a hormone receptor-positive breast" exact="cancer" post="model [32,33]. Only one study has investigated the effect"/>
  <result pre="also demonstrated the anticancer properties of oleamide on human myelogenous" exact="leukemia" post="cell K562 and human squamous cell carcinoma SCC-15. 2."/>
  <result pre="Different Cancer Cell Lines TNBC is an aggressive form of" exact="breast cancer" post="with high metastasis. We determined the effects of the"/>
  <result pre="Cancer Cell Lines TNBC is an aggressive form of breast" exact="cancer" post="with high metastasis. We determined the effects of the"/>
  <result pre="we further investigated the effect of oleamide on two different" exact="cancer" post="cell lines, including human myelogenous leukemia cell K562 and"/>
  <result pre="oleamide on two different cancer cell lines, including human myelogenous" exact="leukemia" post="cell K562 and human squamous cell carcinoma lines SCC-15."/>
  <result pre="possesses several biological activities especially sleep induction [56] and immunological" exact="suppression" post="[57]. Moreover, oleamide has been reported to inhibit gap"/>
  <result pre="has been reported to inhibit gap junction communication on human" exact="breast cancer" post="MDA-MB-231 cells [58,59]. It has been reported that 9-octadecenoic"/>
  <result pre="been reported to inhibit gap junction communication on human breast" exact="cancer" post="MDA-MB-231 cells [58,59]. It has been reported that 9-octadecenoic"/>
  <result pre="study, we demonstrate the anticancer activity of these compounds against" exact="breast cancer" post="cells; we found that oleamide exhibits the strongest anticancer"/>
  <result pre="we demonstrate the anticancer activity of these compounds against breast" exact="cancer" post="cells; we found that oleamide exhibits the strongest anticancer"/>
  <result pre="study demonstrated that the anticancer efficacy of oleamide with other" exact="cancer" post="cell lines, including human myelogenous leukemia cell K562 and"/>
  <result pre="of oleamide with other cancer cell lines, including human myelogenous" exact="leukemia" post="cell K562 and human squamous cell carcinoma lines SCC-15,"/>
  <result pre="which revealed that oleamide has potential anticancer activity for other" exact="cancer" post="types. Recently, patient-derived cancer models have been proposed to"/>
  <result pre="has potential anticancer activity for other cancer types. Recently, patient-derived" exact="cancer" post="models have been proposed to gradually replace the cancer"/>
  <result pre="patient-derived cancer models have been proposed to gradually replace the" exact="cancer" post="cell lines for translational research [65,66,67]. For example, lung"/>
  <result pre="the cancer cell lines for translational research [65,66,67]. For example," exact="lung cancer" post="patients derived samples were studied the effective drug combination"/>
  <result pre="cancer cell lines for translational research [65,66,67]. For example, lung" exact="cancer" post="patients derived samples were studied the effective drug combination"/>
  <result pre="(1-phenyl-2-pentanol), and no. 9 (oleamide) against MDA-MB-231 cell and other" exact="cancer" post="lines including SCC-15 and K562. Therefore, further investigation of"/>
  <result pre="J. Med.20103631938194810.1056/NEJMra100138921067385 5.AndreF.ZielinskiC.C.Optimal strategies for the treatment of metastatic triple-negative" exact="breast cancer" post="with currently approved agentsAnn. Oncol. Off. J. Eur. Soc."/>
  <result pre="Med.20103631938194810.1056/NEJMra100138921067385 5.AndreF.ZielinskiC.C.Optimal strategies for the treatment of metastatic triple-negative breast" exact="cancer" post="with currently approved agentsAnn. Oncol. Off. J. Eur. Soc."/>
  <result pre="Off. J. Eur. Soc. Med Oncol.201223Suppl. 6vi46vi5110.1093/annonc/mds195 6.OdleT.G.Adverse effects of" exact="breast cancer" post="treatmentRadiol. Technol.201485297M323M24395894 7.ThurberM.D.FaheyJ.W.Adoption of Moringa oleifera to combat under-nutrition"/>
  <result pre="J. Eur. Soc. Med Oncol.201223Suppl. 6vi46vi5110.1093/annonc/mds195 6.OdleT.G.Adverse effects of breast" exact="cancer" post="treatmentRadiol. Technol.201485297M323M24395894 7.ThurberM.D.FaheyJ.W.Adoption of Moringa oleifera to combat under-nutrition"/>
  <result pre="Its Free CounterpartAsian Pac. J. Cancer Prev.2017182141214910.22034/apjcp.2017.18.8.214128843248 33.AdebayoI.A.ArsadH.SamianM.R.Antiproliferative effect on" exact="breast cancer" post="(MCF7) of Moringa oleifera seed extractsAfr. J. Tradit Complement."/>
  <result pre="Free CounterpartAsian Pac. J. Cancer Prev.2017182141214910.22034/apjcp.2017.18.8.214128843248 33.AdebayoI.A.ArsadH.SamianM.R.Antiproliferative effect on breast" exact="cancer" post="(MCF7) of Moringa oleifera seed extractsAfr. J. Tradit Complement."/>
  <result pre="PetrocellisL.MechoulamR.Di MarzoV.The sleep inducing factor oleamide is produced by mouse" exact="neuroblastoma" post="cellsBiochem. Biophys. Res. Commun.199723947347910.1006/bbrc.1997.74319344854 57.MoonS.M.LeeS.A.HongJ.H.KimJ.S.KimD.K.KimC.S.Oleamide suppresses inflammatory responses in"/>
  <result pre="modelInt. Immunopharmacol.20185617918510.1016/j.intimp.2018.01.03229414648 58.ZibaraK.AwadaZ.DibL.El-SaghirJ.Al-GhadbanS.IbrikA.El-ZeinN.El-SabbanM.Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231" exact="breast cancer" post="cell invasion and metastasis in vitro and in vivoSci."/>
  <result pre="Immunopharmacol.20185617918510.1016/j.intimp.2018.01.03229414648 58.ZibaraK.AwadaZ.DibL.El-SaghirJ.Al-GhadbanS.IbrikA.El-ZeinN.El-SabbanM.Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast" exact="cancer" post="cell invasion and metastasis in vitro and in vivoSci."/>
  <result pre="inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative" exact="breast cancer" post="to EGFR-targeted therapyBreast Cancer Res.2019217710.1186/s13058-019-1161-931262335 63.TangJ.GautamP.GuptaA.HeL.TimonenS.AkimovY.WangW.SzwajdaA.JaiswalA.TureiD.et al.Network pharmacology modeling"/>
  <result pre="screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast" exact="cancer" post="to EGFR-targeted therapyBreast Cancer Res.2019217710.1186/s13058-019-1161-931262335 63.TangJ.GautamP.GuptaA.HeL.TimonenS.AkimovY.WangW.SzwajdaA.JaiswalA.TureiD.et al.Network pharmacology modeling"/>
  <result pre="interaction in triple-negative breast cancerNPJ Syst. Biol. Appl.201952010.1038/s41540-019-0098-z31312514 64.ChavezK.J.GarimellaS.V.LipkowitzS.Triple negative" exact="breast cancer" post="cell lines: One tool in the search for better"/>
  <result pre="in triple-negative breast cancerNPJ Syst. Biol. Appl.201952010.1038/s41540-019-0098-z31312514 64.ChavezK.J.GarimellaS.V.LipkowitzS.Triple negative breast" exact="cancer" post="cell lines: One tool in the search for better"/>
  <result pre="acid) exhibited anticancer effects through inducing cell cycle arrest. Additionally," exact="suppression" post="of Bcl-2 resulting in the disruption of mitochondrial membrane"/>
 </snippets>
</snippetsTree>
